Screening for Type 2 diabetes. Lessons from the ADDITION-Europe study

Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study

(2010) L. A. Sargeant et al.   DIABETIC MEDICINE

Screening for type 2 diabetes—where are we now?

(2010) Guy Rutten   LANCET

Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis

(2010) Richard Kahn et al.   LANCET

Rationale and design of the ADDITION-Leicester study, a systematic screening programme and Randomised Controlled Trial of multi-factorial cardiovascular risk intervention in people with Type 2 Diabetes Mellitus detected by screening

(2010) DR Webb et al.   Trials

Yield of Opportunistic Targeted Screening for Type 2 Diabetes in Primary Care: The Diabscreen Study

(2009) E. P. Klein Woolthuis et al.   ANNALS OF FAMILY MEDICINE

The ADDITION-Cambridge trial protocol: a cluster – randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients

(2009) Justin B Echouffo-Tcheugui et al.   BMC PUBLIC HEALTH

Do characteristics of practices and general practitioners influence the yield of diabetes screening in primary care? The ADDITION Netherlands study

(2008) Paul G. H. Janssen et al.   SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE